Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-20-041824

Chief Financial Officer gave up 31,873 shares (to pay taxes)

  • Chief Financial Officer acquired 109,459 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Green John L. Chief Financial Officer 2020-07-06 Option exercise +109,459 109,459 D
Green John L. Chief Financial Officer 2020-07-06 Shares withheld for taxes −31,873 $2.20 $70,121 77,586 D
Derivatives
Green John L. Chief Financial Officer 2020-07-06 Option exercise · Restricted Stock Units −109,459 0 D
Loading xslF345X03/doc4.xml…